Age-Specific Seroprevalence of Human Papillomavirus 16, 18, 31, and 58 in Women of a Rural Town of Colombia

Bedoya, Astrid Milena; Gaviria, Ángela; Baena, Armando; Borrero, Mauricio; Duarte, Diego F.; Cómbita, Alba Lucía; Castaño, Jorge; Grisales, Hugo; Sánchez, Gloria Inés

doi:10.1097/igc.0b013e31823c2469

Cited by 17 publications

(20 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Increased number of sexual partners is another known co-factor for HPV infection [12,13,23,30]. Overall HPV prevalence in Peruvian female sex workers (FSW) ranges from 50.6 to 66.8%, which is comparable to Burkina Faso (66.1%), Guatemala (67.3%), the Philippines (57.2%), and Japan (52.6%) [13].…”

Section: Population Specific Prevalence and Sequela Of Hpv In The Andmentioning

confidence: 75%

“…A dual peak head and neck HPV prevalence has also been found in Colombian men and women with HNSCC [7]. Rural, lower socioeconomic status female Colombian teenagers may have a 35.4 to 36% HPV prevalence [23,24]. For female Colombian teenagers four years after coitarche HPV prevalence increases to 42.5%, whereas other female Colombians have a HPV prevalence ranging from 14.8 to 28.2% [14,23].…”

Section: Population Specific Prevalence and Sequela Of Hpv In The Andmentioning

confidence: 94%

“…Rural, lower socioeconomic status female Colombian teenagers may have a 35.4 to 36% HPV prevalence [23,24]. For female Colombian teenagers four years after coitarche HPV prevalence increases to 42.5%, whereas other female Colombians have a HPV prevalence ranging from 14.8 to 28.2% [14,23]. Simultaneous multiple HR genotype HPV infections occur in 29.4% of Colombian women [24].…”

Section: Population Specific Prevalence and Sequela Of Hpv In The Andmentioning

confidence: 99%

“…Education programs should realize that rural-urban dichotomies vary from one nation to another: HPV prevalence in rural Bolivia can be <17%, but in rural Colombia >35%, and rural Peruvian parents decide quicker to accept HPV vaccination than do urban Peruvian parents [23][24][25]36]. Preventive health campaigns may highlight that hormonal contraception normally induces a hypoestrogenic state, removing a co-factor for HPV infection severity [23]. Acknowledgement of vaccinator training for safe vaccine administration and reassurance of expected minor adverse effects including injection site pain should be included in public education campaigns [37].…”

Section: Means For Changing Attitudes Towards Hpv Vaccinationmentioning

confidence: 99%

“…Education should include safe sex practices and the need to reduce the lifetime number of sexual partners: Only 31.1% of sampled Chilean adolescents used condoms; 77% of HIV-negative Peruvian MSM and TW have condom-less anal or oral sex; In Colombia, age-specific HPV-16, -18, -31, and -58 prevalence is associated with more lifetime sexual partners; multiple sexual partners is a CC risk factor [23,32,40]. Education programs should realize that rural-urban dichotomies vary from one nation to another: HPV prevalence in rural Bolivia can be <17%, but in rural Colombia >35%, and rural Peruvian parents decide quicker to accept HPV vaccination than do urban Peruvian parents [23][24][25]36].…”

Section: Means For Changing Attitudes Towards Hpv Vaccinationmentioning

confidence: 99%

See 4 more Smart Citations

Attitudes Towards Human Papilloma Virus Vaccination in the Latin American Andean Region

Nwanodi¹

2017

Gynecol Obstet (Sunnyvale)

View full text Add to dashboard Cite

This commentary explores the distribution of human papilloma virus (HPV) and HPV-related diseases, and factors affecting attitudes towards HPV, HPV-related diseases, and HPV vaccination in the Latin American Andean region. Lack of knowledge of HPV, known negative attitudes or incorrect assumptions about HPV, HPV-related diseases, and HPV vaccination provide a basis upon which to develop targeted HPV awareness and preventive health media campaigns. For maximal effect, media campaigns should use the internet, radio, and television to address health care providers, parents, and students. Additional programming can be developed for clinics to use in-house with their clients. Ministries of Education, Finance, and Health all have roles to play to increase national HPV, HPV-related diseases, and HPV vaccination awareness.

show abstract

Section: Population Specific Prevalence and Sequela Of Hpv In The Andmentioning

confidence: 75%

Section: Population Specific Prevalence and Sequela Of Hpv In The Andmentioning

confidence: 94%

Section: Population Specific Prevalence and Sequela Of Hpv In The Andmentioning

confidence: 99%

Section: Means For Changing Attitudes Towards Hpv Vaccinationmentioning

confidence: 99%

Section: Means For Changing Attitudes Towards Hpv Vaccinationmentioning

confidence: 99%

See 3 more Smart Citations

Attitudes Towards Human Papilloma Virus Vaccination in the Latin American Andean Region

Nwanodi¹

2017

Gynecol Obstet (Sunnyvale)

View full text Add to dashboard Cite

show abstract

Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS‐LSIL Triage Study

Wilson

Pawlita

Castle

et al. 2013

Intl Journal of Cancer

View full text Add to dashboard Cite

Only a subset of women with human papillomavirus (HPV) infections will become seropositive, and the factors influencing seroconversion are not well-understood. We used a multiplex serology assay in women with mildly abnormal cytology results to examine seroreactivity to oncogenic HPV genotypes. An unbiased subset of women in the atypical squamous cell of undetermined significance /low-grade squamous intraepithelial lesion Triage Study (ALTS) provided blood samples at trial enrollment for serological testing. A Luminex assay based on GST-L1 fusion proteins as antigens was used to test seroreactivity against eight carcinogenic HPV genotypes (16, 18, 31, 33, 35, 45, 52, 58). We analyzed the relationship between seroprevalence in women free of precancer (N=2464) and HPV DNA status, age, sexual behavior, and other HPV-related risk factors. The overall seroprevalence was 24.5% for HPV16 L1 and ~ 20% for 18L1 and 31L1. Among women free of precancer, seroprevalence peaked in women less than 29 years and decreased with age. Type-specific seroprevalence was associated with baseline DNA detection for HPV16 (OR= 1.36, 95%CI: 1.04–1.79) and HPV18 (OR= 2.31, 95%CI: 1.61–3.32), as well as for HPV52 and HPV58. Correlates of sexual exposure were associated with increased seroprevalence across most genotypes. Women who were current or former smokers were less likely to be seropositive for all eight of the tested oncogenic genotypes. The multiplex assay showed associations between seroprevalence and known risk factors for HPV infection across nearly all tested HPV genotypes but associations between DNA- and serostatus were weak, suggesting possible misclassification of the participants’ HPV serostatus.

show abstract

Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women

Brown

Castellsagué

Ferris³

et al. 2022

Tumour Virus Research

View full text Add to dashboard Cite

Age-Specific Seroprevalence of Human Papillomavirus 16, 18, 31, and 58 in Women of a Rural Town of Colombia

Abstract: Human papillomavirus seropositivity is associated with measures of sexual behavior, particularly a greater lifetime number of sexual partners. Hormonal and tobacco/cigarette use may be factors influencing the HPV seropositivity in women older than 45 years old.

Cited by 17 publications

References 24 publications

Attitudes Towards Human Papilloma Virus Vaccination in the Latin American Andean Region

Attitudes Towards Human Papilloma Virus Vaccination in the Latin American Andean Region

Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS‐LSIL Triage Study

Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women

Contact Info

Product

Resources

About